Practical management of epidermolysis bullosa : consensus clinical position statement from the European Reference Network for Rare Skin Diseases
© 2021 European Academy of Dermatology and Venereology..
Inherited epidermolysis bullosa (EB) comprises rare disorders that manifest with fragility and blistering of the skin and mucous membranes, with variable clinical severity. Management of EB is challenging due to disease rarity and complexity, the wide range of extracutaneous manifestations and a profound impact on daily life for the patient and family members. Although reference centres providing multidisciplinary care for EB exist in each European country, it is common for healthcare professionals that are not specialized in this rare disorder to treat EB patients. Here, experts of the European Reference Network for Rare and Undiagnosed Skin Diseases (ERN-Skin, https://ern-skin.eu) propose practical recommendations for the diagnosis and management of the commonest clinical issues, skin blisters and wounds, oral manifestations, pain and itch.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Journal of the European Academy of Dermatology and Venereology : JEADV - 35(2021), 12 vom: 15. Dez., Seite 2349-2360 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Has, C [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 16.11.2021 Date Revised 16.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/jdv.17629 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330878026 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330878026 | ||
003 | DE-627 | ||
005 | 20231225212233.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jdv.17629 |2 doi | |
028 | 5 | 2 | |a pubmed24n1102.xml |
035 | |a (DE-627)NLM330878026 | ||
035 | |a (NLM)34545960 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Has, C |e verfasserin |4 aut | |
245 | 1 | 0 | |a Practical management of epidermolysis bullosa |b consensus clinical position statement from the European Reference Network for Rare Skin Diseases |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.11.2021 | ||
500 | |a Date Revised 16.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 European Academy of Dermatology and Venereology. | ||
520 | |a Inherited epidermolysis bullosa (EB) comprises rare disorders that manifest with fragility and blistering of the skin and mucous membranes, with variable clinical severity. Management of EB is challenging due to disease rarity and complexity, the wide range of extracutaneous manifestations and a profound impact on daily life for the patient and family members. Although reference centres providing multidisciplinary care for EB exist in each European country, it is common for healthcare professionals that are not specialized in this rare disorder to treat EB patients. Here, experts of the European Reference Network for Rare and Undiagnosed Skin Diseases (ERN-Skin, https://ern-skin.eu) propose practical recommendations for the diagnosis and management of the commonest clinical issues, skin blisters and wounds, oral manifestations, pain and itch | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a El Hachem, M |e verfasserin |4 aut | |
700 | 1 | |a Bučková, H |e verfasserin |4 aut | |
700 | 1 | |a Fischer, P |e verfasserin |4 aut | |
700 | 1 | |a Friedová, M |e verfasserin |4 aut | |
700 | 1 | |a Greco, C |e verfasserin |4 aut | |
700 | 1 | |a Nevoránková, P |e verfasserin |4 aut | |
700 | 1 | |a Salavastru, C |e verfasserin |4 aut | |
700 | 1 | |a Mellerio, J E |e verfasserin |4 aut | |
700 | 1 | |a Zambruno, G |e verfasserin |4 aut | |
700 | 1 | |a Bodemer, C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the European Academy of Dermatology and Venereology : JEADV |d 1997 |g 35(2021), 12 vom: 15. Dez., Seite 2349-2360 |w (DE-627)NLM091705932 |x 1468-3083 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2021 |g number:12 |g day:15 |g month:12 |g pages:2349-2360 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jdv.17629 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2021 |e 12 |b 15 |c 12 |h 2349-2360 |